Clinical Trials Browser

Phase 3 × INDUSTRY × Platinum-Resistant Primary Peritoneal Carcinoma × Clear all

NCT06867562 2025-03-10

Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer

Phase 3 Not yet recruiting

Platinum-Resistant Primary Peritoneal Carcinoma